Nadolol in the treatment of central serous retinopathy
- PMID: 8250086
- DOI: 10.1016/s0002-9394(14)73483-x
Nadolol in the treatment of central serous retinopathy
Similar articles
-
The effect of twice daily nadolol on intraocular pressure.Am J Ophthalmol. 1987 Oct 15;104(4):343-5. doi: 10.1016/0002-9394(87)90222-4. Am J Ophthalmol. 1987. PMID: 3661642 Clinical Trial.
-
Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP).Lancet. 1996 Dec 21-28;348(9043):1677-81. doi: 10.1016/s0140-6736(96)05406-2. Lancet. 1996. PMID: 8973428 Clinical Trial.
-
Depression during treatment with beta-blockers: results from a double-blind placebo-controlled study.J Neuropsychiatry Clin Neurosci. 1992 Spring;4(2):187-9. doi: 10.1176/jnp.4.2.187. J Neuropsychiatry Clin Neurosci. 1992. PMID: 1627981 Clinical Trial.
-
Nadolol in the treatment of aggressive behavior associated with schizophrenia.Clin Pharm. 1989 Feb;8(2):132-5. Clin Pharm. 1989. PMID: 2917450 No abstract available.
-
Nadolol reduces insulin sensitivity in liver cirrhosis: a randomized double-blind crossover trial.Diabetes Metab Res Rev. 2017 Mar;33(3). doi: 10.1002/dmrr.2859. Epub 2016 Nov 10. Diabetes Metab Res Rev. 2017. PMID: 27667324 Clinical Trial.
Cited by
-
Oral medications for central serous chorioretinopathy: a literature review.Eye (Lond). 2020 May;34(5):809-824. doi: 10.1038/s41433-019-0568-y. Epub 2019 Sep 16. Eye (Lond). 2020. PMID: 31527760 Free PMC article. Review.
-
Interventions for central serous chorioretinopathy: a network meta-analysis.Cochrane Database Syst Rev. 2015 Dec 22;2015(12):CD011841. doi: 10.1002/14651858.CD011841.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2025 Jun 16;6:CD011841. doi: 10.1002/14651858.CD011841.pub3. PMID: 26691378 Free PMC article. Updated.
-
Central serous chorioretinopathy: a pathogenetic model.Clin Ophthalmol. 2011;5:239-43. doi: 10.2147/OPTH.S17182. Epub 2011 Feb 20. Clin Ophthalmol. 2011. PMID: 21386917 Free PMC article.
-
Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level.Br J Ophthalmol. 2003 Dec;87(12):1453-8. doi: 10.1136/bjo.87.12.1453. Br J Ophthalmol. 2003. PMID: 14660450 Free PMC article.
-
Central serous chorioretinopathy: update on pathophysiology and treatment.Surv Ophthalmol. 2013 Mar-Apr;58(2):103-26. doi: 10.1016/j.survophthal.2012.07.004. Surv Ophthalmol. 2013. PMID: 23410821 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical